Timothy J. Hubin
Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads
Hubin, Timothy J.; Walker, Ashlie N.; Davilla, Dustin J.; Carder Freeman, Ta Rynn N.; Epley, Brittany M.; Hasley, Travis R.; Amoyaw, Prince N.A.; Jain, Surendra; Archibald, Stephen J.; Prior, Timothy J.; Krause, Jeanette A.; Oliver, Allen G.; Tekwani, Babu L.; Khan, M. Omar F.
Authors
Ashlie N. Walker
Dustin J. Davilla
Ta Rynn N. Carder Freeman
Brittany M. Epley
Travis R. Hasley
Prince N.A. Amoyaw
Surendra Jain
Professor Steve Archibald S.J.Archibald@hull.ac.uk
Professor in Molecular Imaging
Dr Tim Prior T.Prior@hull.ac.uk
Senior Lecturer in Inorganic Chemistry
Jeanette A. Krause
Allen G. Oliver
Babu L. Tekwani
M. Omar F. Khan
Abstract
© 2019 A total of 44 bis-aryl-monocyclic polyamines, monoaryl-monocyclic polyamines and their transition metal complexes were prepared, chemically characterized, and screened in vitro against the Leishmania donovani promastigotes, axenic amastigotes and intracellular amastigotes in THP1 cells. The IC 50 and/or IC 90 values showed that 10 compounds were similarly active at about 2-fold less potent than known drug pentamidine against promastigotes. The most potent compound had an IC 50 of 2.82 µM (compared to 2.93 µM for pentamidine). Nine compounds were 1.1–13.6-fold more potent than pentamidine against axenic amastigotes, the most potent one being about 2-fold less potent than amphotericin B. Fourteen compounds were about 2–10 fold more potent than pentamidine, the most potent one is about 2-fold less potent than amphotericin B against intracellular amastigotes in THP1 cells. The 2 most promising compounds (FeL7Cl 2 and MnL7Cl 2 ), with strong activity against both promastigotes and amastigotes and no observable toxicity against the THP1 cells are the Fe 2+ - and Mn 2+ -complexes of a dibenzyl cyclen derivative. Only 2 of the 44 compounds showed observable cytotoxicity against THP1 cells. Tetraazamacrocyclic monocyclic polyamines represent a new class of antileishmanial lead structures that warrant follow up studies.
Citation
Hubin, T. J., Walker, A. N., Davilla, D. J., Carder Freeman, T. R. N., Epley, B. M., Hasley, T. R., Amoyaw, P. N., Jain, S., Archibald, S. J., Prior, T. J., Krause, J. A., Oliver, A. G., Tekwani, B. L., & Khan, M. O. F. (2019). Tetraazamacrocyclic derivatives and their metal complexes as antileishmanial leads. Polyhedron, 163, 42-53. https://doi.org/10.1016/j.poly.2019.02.027
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 14, 2019 |
Online Publication Date | Feb 23, 2019 |
Publication Date | May 1, 2019 |
Deposit Date | Mar 29, 2019 |
Publicly Available Date | Mar 29, 2019 |
Journal | Polyhedron |
Print ISSN | 0277-5387 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 163 |
Pages | 42-53 |
DOI | https://doi.org/10.1016/j.poly.2019.02.027 |
Keywords | Cyclen; Cyclam; Polyamine; Antileishmanial drug lead; Metal complexes |
Public URL | https://hull-repository.worktribe.com/output/1357749 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S0277538719301287?via%3Dihub |
Contract Date | Mar 29, 2019 |
Files
Article
(952 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
You might also like
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search